Effects of cholinergic agonists and antagonists on self-stimulation behavior in the rat.
D000818:Animals; D001285:Atropine / Q000494:pharmacology; D003216:Conditioning, Operant / Q000187:drug effects*; D004558:Electric Stimulation; D004567:Electrodes, Implanted; D007031:Hypothalamus / Q000187:drug effects*; D007274:Injections, Intraperitoneal; D008297:Male; D008464:Mecamylamine / Q000494:pharmacology; D008694:Methamphetamine / Q000494:pharmacology; D009388:Neostigmine / Q000494:pharmacology; D009538:Nicotine / Q000494:pharmacology; D010276:Parasympatholytics / Q000494:pharmacology*; D010277:Parasympathomimetics / Q000494:pharmacology*; D010830:Physostigmine / Q000494:pharmacology; D010862:Pilocarpine / Q000494:pharmacology; D051381:Rats; D011950:Receptors, Cholinergic / Q000187:drug effects; D012601:Scopolamine / Q000494:pharmacology; D012653:Self Stimulation
D010276:Parasympatholytics; D010277:Parasympathomimetics; D011950:Receptors, Cholinergic; D010862:Pilocarpine; D009388:Neostigmine; D008694:Methamphetamine; D008464:Mecamylamine; D009538:Nicotine; D001285:Atropine; D010830:Physostigmine; D012601:Scopolamine